
THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:
INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTIL
CHINA SXT PHARM. NEW O.N. 2RY VGG2161P1577 BAW/UFN
© 2025 Xetra Newsboard
Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
Fr | China SXT Pharmaceuticals, Inc. - S-8, Securities to be offered to employees in employee benefit plans | ||
Fr | China SXT Pharmaceuticals, Inc. - 6-K, Report of foreign issuer | ||
19.03. | China SXT Pharmaceuticals, Inc. - 6-K, Report of foreign issuer | ||
17.03. | China SXT Pharmaceuticals, Inc.: China SXT Pharmaceuticals Has Regained Compliance with Nasdaq's Minimum Bid Price Deficiency | TAIZHOU, China, March 17, 2025 (GLOBE NEWSWIRE) -- China SXT Pharmaceuticals, Inc. (Nasdaq: SXTC) (the "Company"), a specialty pharmaceutical company focusing on the research, development, manufacturing... ► Artikel lesen | |
26.02. | XFRA 2RY: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILCHINA SXT PHARM.... ► Artikel lesen |
Unternehmen / Aktien | Kurs | % |
---|---|---|
CHINA SXT PHARMACEUTICALS INC | 2,820 | -0,35 % |